Header Logo

Connection

Kyle Amber to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Kyle Amber has written about Diabetes Mellitus, Type 2.
Kyle Amber
Connection Strength
0.127
Diabetes Mellitus, Type 2
  1. Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study. Immunol Res. 2018 06; 66(3):425-430.
    View in: PubMed
    Score: 0.127
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.